These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31294521)

  • 1. Prevalence, mortality and healthcare utilization among Medicare beneficiaries with Hepatitis C in Haemodialysis units.
    Deshpande R; Stepanova M; Golabi P; Brown K; Younossi ZM
    J Viral Hepat; 2019 Nov; 26(11):1293-1300. PubMed ID: 31294521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study.
    Younossi ZM; Zheng L; Stepanova M; Venkatesan C; Mishra A
    BMJ Open; 2014 May; 4(5):e004318. PubMed ID: 24838722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Biliary Cholangitis in Medicare Population: The Impact on Mortality and Resource Use.
    Sayiner M; Golabi P; Stepanova M; Younossi I; Nader F; Racila A; Younossi ZM
    Hepatology; 2019 Jan; 69(1):237-244. PubMed ID: 30015376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Direct-Acting Antiviral Treatment With Mortality Among Medicare Beneficiaries With Hepatitis C.
    Kalidindi Y; Jung J; Feldman R; Riley T
    JAMA Netw Open; 2020 Jul; 3(7):e2011055. PubMed ID: 32692371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of hepatitis C (HCV) infection in Baby Boomers with Medicare is independently associated with mortality and resource utilisation.
    Sayiner M; Wymer M; Golabi P; Ford J; Srishord I; Younossi ZM
    Aliment Pharmacol Ther; 2016 May; 43(10):1060-8. PubMed ID: 26991652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resource Utilization and Outcomes of Medicare Recipients With Chronic Hepatitis B in the United States.
    Kim M; Paik J; Golabi P; Jeffers T; Mishra A; Younossi ZM
    J Clin Gastroenterol; 2019 Sep; 53(8):e341-e347. PubMed ID: 30106839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients.
    Alavian SM; Einollahi B; Hajarizadeh B; Bakhtiari S; Nafar M; Ahrabi S
    Nephrology (Carlton); 2003 Oct; 8(5):256-60. PubMed ID: 15012714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver disease.
    Younossi ZM; Zheng L; Stepanova M; Henry L; Venkatesan C; Mishra A
    J Clin Gastroenterol; 2015 Mar; 49(3):222-7. PubMed ID: 24637730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients.
    Espinosa M; Martin-Malo A; Alvarez de Lara MA; Aljama P
    Nephrol Dial Transplant; 2001 Aug; 16(8):1669-74. PubMed ID: 11477172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca].
    Boulaajaj K; Elomari Y; Elmaliki B; Madkouri B; Zaid D; Benchemsi N
    Nephrol Ther; 2005 Nov; 1(5):274-84. PubMed ID: 16895696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey.
    Sauné K; Kamar N; Miédougé M; Weclawiak H; Dubois M; Izopet J; Rostaing L
    Nephrol Dial Transplant; 2011 Jul; 26(7):2309-16. PubMed ID: 21097646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The susceptibility of patients with type-2 diabetes to hepatitis C virus infection during long-term haemodialysis.
    Saxena AK; Panhotra BR
    Swiss Med Wkly; 2003 Dec; 133(45-46):611-8. PubMed ID: 14745667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for hepatitis C virus sero-positivity among haemodialysis patients receiving care at kidney centre in a tertiary health facility in Maiduguri, Nigeria.
    Ummate I; Denue BA; Kida IM; Ohioma OJ; Baba DB; Goni W
    Pan Afr Med J; 2014; 19():305. PubMed ID: 25883732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C prevalence studied by polymerase chain reaction and serological methods in haemodialysis patients in Mazandaran, Iran.
    Makhlough A; Jamshidi M; Mahdavi MR
    Singapore Med J; 2008 Nov; 49(11):921-3. PubMed ID: 19037560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis-requiring acute kidney injury among hospitalized adults with documented hepatitis C Virus infection: a nationwide inpatient sample analysis.
    Nadkarni GN; Patel A; Simoes PK; Yacoub R; Annapureddy N; Kamat S; Konstantinidis I; Perumalswami P; Branch A; Coca SG; Wyatt CM
    J Viral Hepat; 2016 Jan; 23(1):32-8. PubMed ID: 26189719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variables Associated With Inpatient and Outpatient Resource Utilization Among Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease With or Without Cirrhosis.
    Sayiner M; Otgonsuren M; Cable R; Younossi I; Afendy M; Golabi P; Henry L; Younossi ZM
    J Clin Gastroenterol; 2017 Mar; 51(3):254-260. PubMed ID: 27332747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Direct-Acting Antiviral Therapy for Hepatitis C With After-Treatment Costs Among Medicare Beneficiaries.
    Jung J; Feldman R; Kalidindi Y; Riley T
    JAMA Netw Open; 2020 Jun; 3(6):e208081. PubMed ID: 32602909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Holiday haemodialysis and imported hepatitis C virus infection: a series of sixteen cases in two large haemodialysis units.
    Bhattacharya S; Price N; Boxall E; Adu D; Lipkin G; Smith S; Osman H
    J Clin Virol; 2009 Aug; 45(4):296-9. PubMed ID: 19451020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Travel-associated acquisition of hepatitis C virus infection in patients receiving haemodialysis.
    Ghafur A; Raza M; Labbett W; Chawla A; Smith C; Ngui SL; Davenport A; Geretti AM
    Nephrol Dial Transplant; 2007 Sep; 22(9):2640-4. PubMed ID: 17535845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease.
    Mederacke I; Meier M; Lüth JB; Schmidt-Gürtler H; Raupach R; Horn-Wichmann R; Wursthorn K; Potthoff A; Colucci G; Manns MP; Wedemeyer H; Tillmann HL
    Nephrol Dial Transplant; 2011 Aug; 26(8):2648-56. PubMed ID: 21273235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.